Phase II Trial of Natalizumab (Tysabri?) with Corticosteroids as Initial Treatment of Gastrointestinal Acute Graft Versus Host Disease

著录项

• 来源
  《Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation》 |2018年第3期|共1页
• 作者

  Natasha Kekre; Haesook T. Kim; Vincent T. Ho; Yikun Guo; Umair Mahmood; Wafae Belatreche; John Koreth; Philippe Armand; Sarah Nikiforow; Edwin P. Alyea; Prashant Nageshwar; Brett Glotzbecker; Areej R. El-Jawahri; Robert J. Soiffer; Joseph H. Antin; Yi-Bin Chen; Corey Cutler;

  展开▼
• 作者单位

  The Ottawa Hospital Research Institute;

  Department of Biostatistics and Computational Biology Dana-Farber Cancer Institute;

  Division of Hematologic Malignancies Dana-Farber Cancer Institute;

  Dana Farber Cancer Institute;

  Dana Farber Cancer Institute;

  Dana Farber Cancer Institute;

  Division of Hematologic Malignancies Dana-Farber Cancer Institute;

  Division of Hematologic Malignancies Dana-Farber Cancer Institute;

  Division of Hematologic Malignancies Dana-Farber Cancer Institute;

  Hematologic Malignancies Dana-Farber Cancer Institute Harvard Medical School;

  Dana-Farber Cancer Institute;

  Hematologic Malignancies Dana-Farber Cancer Institute Harvard Medical School;

  Hematology/Oncology Massachusetts General Hospital Harvard Medical School;

  Hematologic Malignancies Dana-Farber Cancer Institute Harvard Medical School;

  Division of Hematologic Malignancies Dana-Farber Cancer Institute;

  Blood and Marrow Transplant Program Massachusetts General Hospital;

  Dana-Farber Cancer Institute;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 治疗学;
• 关键词